Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 470

1.

Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.

Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J.

Am J Kidney Dis. 2013 Jan;61(1):67-73. doi: 10.1053/j.ajkd.2012.06.022. Epub 2012 Aug 9.

2.

Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome.

deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, Wolf M, Gaggin H, Januzzi J.

Clin Chem. 2012 Sep;58(9):1342-51. doi: 10.1373/clinchem.2012.185322. Epub 2012 Jul 12.

3.

Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.

Seeherunvong W, Abitbol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M.

Pediatr Nephrol. 2012 Nov;27(11):2129-36. doi: 10.1007/s00467-012-2224-7. Epub 2012 Jun 19.

PMID:
22710695
4.

Cardiac troponins and renal function in nondialysis patients with chronic kidney disease.

Abbas NA, John RI, Webb MC, Kempson ME, Potter AN, Price CP, Vickery S, Lamb EJ.

Clin Chem. 2005 Nov;51(11):2059-66. Epub 2005 Sep 15.

5.

Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.

Unsal A, Kose Budak S, Koc Y, Basturk T, Sakaci T, Ahbap E, Sinangil A.

Kidney Blood Press Res. 2012;36(1):55-64. doi: 10.1159/000339026. Epub 2012 Aug 6.

PMID:
22854270
6.

Association of cardiac troponin T with left ventricular structure and function in CKD.

Mishra RK, Li Y, DeFilippi C, Fischer MJ, Yang W, Keane M, Chen J, He J, Kallem R, Horwitz EJ, Rafey M, Raj DS, Go AS, Shlipak MG; CRIC Study Investigators.

Am J Kidney Dis. 2013 May;61(5):701-9. doi: 10.1053/j.ajkd.2012.11.034. Epub 2013 Jan 4.

7.

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M.

Circulation. 2009 May 19;119(19):2545-52. doi: 10.1161/CIRCULATIONAHA.108.844506. Epub 2009 May 4.

8.

Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Buiten MS, de Bie MK, Rotmans JI, Dekker FW, van Buren M, Rabelink TJ, Cobbaert CM, Schalij MJ, van der Laarse A, Jukema JW.

PLoS One. 2015 Aug 3;10(8):e0134245. doi: 10.1371/journal.pone.0134245. eCollection 2015.

9.
10.

Defining high-sensitivity cardiac troponin concentrations in the community.

McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS.

Clin Chem. 2013 Jul;59(7):1099-107. doi: 10.1373/clinchem.2012.198614. Epub 2013 Apr 16.

11.

Upper reference limits of high-sensitivity cardiac troponin T in a general population: comparison with those of sensitive cardiac troponin I.

Chenevier-Gobeaux C, Bailleul S, Mzabi A, Blanc MC, Lefevre G.

Clin Lab. 2013;59(3-4):333-6.

PMID:
23724622
12.

Fibroblast growth factor-23 and cardiac structure and function.

Agarwal I, Ide N, Ix JH, Kestenbaum B, Lanske B, Schiller NB, Whooley MA, Mukamal KJ.

J Am Heart Assoc. 2014 Feb 13;3(1):e000584. doi: 10.1161/JAHA.113.000584.

13.

Predictive value of cardiac troponin T and I in hemodialysis patients.

Kalaji FR, Albitar S.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):939-45. doi: 10.4103/1319-2442.100868.

14.

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W.

JAMA. 2003 Jul 16;290(3):353-9.

PMID:
12865376
15.
16.

Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.

Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, Takagi M, Sato M, Nagahama L, Omote K, Hisada A, Horikoshi S, Tomino Y.

J Nephrol. 2012 Sep-Oct;25(5):794-801. doi: 10.5301/jn.5000066.

PMID:
22241636
17.

Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.

de Antonio M, Lupón J, Galán A, Vila J, Zamora E, Urrutia A, Díez C, Coll R, Altimir S, Bayes-Genis A.

Clin Chim Acta. 2013 Nov 15;426:18-24. doi: 10.1016/j.cca.2013.08.014. Epub 2013 Aug 23.

PMID:
23978483
18.

Is cardiac biomarkers and left ventricular function affected by chronic kidney disease?

Zand Parsa AF, Abdolahi A, Mahdavimazdeh M.

Indian Heart J. 2012 Sep-Oct;64(5):479-83. doi: 10.1016/j.ihj.2012.08.003. Epub 2012 Aug 27.

19.

FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.

Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE.

Clin J Am Soc Nephrol. 2012 Dec;7(12):2017-22. doi: 10.2215/CJN.02160212. Epub 2012 Sep 20.

20.

Serum cardiac troponin T, troponin I, plasma BNP and left ventricular mass index in professional football players.

Löwbeer C, Seeberger A, Gustafsson SA, Bouvier F, Hulting J.

J Sci Med Sport. 2007 Oct;10(5):291-6. Epub 2007 Feb 6.

PMID:
17289431
Items per page

Supplemental Content

Write to the Help Desk